The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Lung-MAP (SWOG S1400): Design, implementation, and lessons learned from a biomarker-driven master protocol (BDMP) for previously-treated squamous lung cancer (sqNSCLC).
 
Mary Weber Redman
Consulting or Advisory Role - Ignyta; Ignyta
 
Vassiliki Papadimitrakopoulou
Employment - Pfizer
Honoraria - Roche
Consulting or Advisory Role - Abbvie; Araxes Pharma; ARIAD; Arrys Therapeutics; AstraZeneca; Biothera; Bolt Biotherapeutics; Bristol-Myers Squibb; Clovis Oncology; Exelixis; G2 Innovation; Genentech; Genentech; Gritstone Bio; Janssen; Leads Biolabs; Lilly; Loxo; Merck; Nektar; Novartis; Pfizer; Takeda; Tesaro; TRM Oncology
Research Funding - ACEA Biosciences (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Checkmate Pharmaceuticals (Inst); Checkmate Pharmaceuticals (Inst); Checkmate Pharmaceuticals (Inst); Clovis Oncology (Inst); Guardant Health (Inst); Incyte (Inst); Janssen Oncology (Inst); Lilly (Inst); Merck (Inst); Nektar (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Roche; Roche
Other Relationship - Roche
 
Katherine Minichiello
No Relationships to Disclose
 
David R. Gandara
Consulting or Advisory Role - Amgen; AstraZeneca (Inst); Boehringer Ingelheim; CellMax Life (Inst); Guardant Health (Inst); Inivata; IO Biotech (Inst); Lilly; Merck; OncoCyte (Inst); Pfizer; Roche/Genentech
Research Funding - AstraZeneca/MedImmune (Inst); Merck (Inst); Merck (Inst); Roche/Genentech (Inst)
 
Fred R. Hirsch
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Genentech; Lilly; Loxo; Merck; Novartis; Oncocyte; Pfizer; Roche
Research Funding - Abbvie (Inst); Amgen (Inst); Biodesix (Inst); Merck (Inst); Mersana (Inst); Rain Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - EGFR FISH and IHC for prediction of outcome in patients treated with EGFR inhibitors (Inst)
 
Philip C. Mack
Honoraria - Guardant Health
Consulting or Advisory Role - Amgen; AstraZeneca; Guardant Health
Research Funding - Boehringer Ingelheim
 
Lawrence Howard Schwartz
Consulting or Advisory Role - Novartis; Regeneron
Research Funding - Boehringer Ingelheim (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Varian Medical Systems
 
Everett E. Vokes
Stock and Other Ownership Interests - Coordination Pharmaceuticals
Honoraria - Abbvie; Amgen; Ascendis Pharma (I); AstraZeneca; Bristol-Myers Squibb; Celgene; EMD Serono; Genentech; GlaxoSmithKline; Lilly; Merck; Novartis; Radius Health (I); Regeneron; Takeda (I)
Consulting or Advisory Role - Abbvie; Amgen; Ascendis Pharma (I); AstraZeneca; Bristol-Myers Squibb; Celgene; EMD Serono; Genentech; GlaxoSmithKline; Lilly; Merck; Novartis; Radius Health (I); Regeneron; Takeda (I)
Research Funding - Abbvie; Bristol-Myers Squibb; Celgene; Novartis
Travel, Accommodations, Expenses - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; EMD Serono; Genentech; GlaxoSmithKline; Lilly; Merck; Novartis; Regeneron
 
Suresh S. Ramalingam
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Lilly/ImClone; Loxo; Merck; Nektar; Takeda; Tesaro
Research Funding - Abbvie (Inst); Advaxis (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Genmab (Inst); Merck (Inst); Merck (Inst); Pfizer (Inst); Takeda (Inst); Vertex (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Natasha B. Leighl
Consulting or Advisory Role - Xcovery
Research Funding - Array BioPharma (Inst); Guardant Health (Inst); Novartis (Inst); Roche Canada (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Nektar; Roche
 
Jeffrey Bradley
Consulting or Advisory Role - AstraZeneca
 
Michael Leo LeBlanc
Consulting or Advisory Role - Agios
 
Shakuntala Malik
No Relationships to Disclose
 
Vincent A. Miller
Employment - Foundation Medicine
Leadership - Foundation Medicine; Revolution Medicines
Stock and Other Ownership Interests - Foundation Medicine; Mirati Therapeutics; Revolution Medicines
Patents, Royalties, Other Intellectual Property - Receive periodic royalties related to T790M patent awarded to Memorial Sloan Kettering Cancer Center
 
Ellen V. Sigal
Travel, Accommodations, Expenses - Deerfield Management; Forest Laboratories/Actavis; H3 Biomedicine
 
Stacey Adam
No Relationships to Disclose
 
Charles David Blanke
No Relationships to Disclose
 
Karen Kelly
Honoraria - Merck
Consulting or Advisory Role - Abbvie; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; EMD Serono; Genentech/Roche; Inivata; Merck; Novartis; Pfizer; Regeneron; Symphogen
Research Funding - Abbvie (Inst); Astellas Pharma; Bristol-Myers Squibb; EMD Serono (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); Regeneron (Inst); Tizona Therapeutics, Inc.; Transgene
Patents, Royalties, Other Intellectual Property - Author Royalties for UpToDate, an evidence based, peer reviewed information resource, available via the web, desktop, and PDA.
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; EMD Serono; Genentech/Roche; Lilly; Merck; Merck; Regeneron
 
Roy S. Herbst
Leadership - Junshi Pharmaceuticals
Consulting or Advisory Role - Abbvie; ARMO Biosciences; AstraZeneca; Biodesix; Bolt Biotherapeutics; Bristol-Myers Squibb; EMD Serono; Genentech/Roche; Genmab; Halozyme; Heat Biologics; I-Mab; Immunocore; Infinity Pharmaceuticals; Junshi Pharmaceuticals; Lilly; Loxo; Merck; Midas Health Analytics; Mirati Therapeutics; Nektar; Neon Therapeutics; NextCure; Novartis; Pfizer; Sanofi; Seagen; Shire; Spectrum Pharmaceuticals; Symphogen; Takeda; TESARO; Tocagen
Research Funding - AstraZeneca; Genentech/Roche; Lilly; Merck